Nasdaq · Healthcare
Quanterix Corp (QTRX)
As-reported financials and recent SEC filings for Quanterix Corp, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$138.9M
Net income
$-107.2M
Net margin
-77.1%
Diluted EPS
$-2.51
ROE
-36.2%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $138.9M | $137.4M | $122.4M | $105.5M | $110.6M |
| Gross profit | $65.0M | $83.1M | $74.2M | $45.4M | $64.8M |
| Operating income | $-125.5M | $-52.6M | $-46.0M | $-104.3M | $-56.5M |
| Net income | $-107.2M | $-38.5M | $-28.4M | $-99.6M | $-55.5M |
| Diluted EPS | $-2.51 | $-1.00 | $-0.75 | $-2.69 | $-1.54 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-07-02
View on EDGAR →42026-07-02
View on EDGAR →42026-07-02
View on EDGAR →42026-06-23
View on EDGAR →32026-06-22
View on EDGAR →42026-06-16
View on EDGAR →42026-06-12
View on EDGAR →32026-06-12
View on EDGAR →Largest Healthcare peers
Go deeper on QTRX
Search Quanterix Corp’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.